人乳头瘤病毒与甲状腺眼病
在Bascom Palmer眼科研究所开展的实验性病例对照研究,对11例甲状腺眼病(TED)患者眶脂肪行减压手术标本与11例对照眼睑成形术标本进行酶联免疫测定,发现HPV18 L1 IgG标准化光密度在对照组与慢性TED、对照组与急性活动性TED、慢性TED与急性活动性TED之间均存在差异,并发现TSHR与IGF-1R同HPV18 L1衣壳蛋白存在保守基序同源性,提示分子模拟可能参与TED发病。
要点
- TSHR与IGF-1R同HPV18 L1衣壳蛋白存在保守基序同源性,FGXV与IXEXT+NP同源区域见于所有HPV血清型及IGF-1R与TSHR。
- 对照组与慢性TED眶脂肪HPV18 L1 IgG标准化光密度平均差-1.37(95%CI -2.64至-0.09,P=0.03)。
- 对照组与急性活动性TED平均差-3.15(95%CI -4.69至-1.61,P<0.001),慢性TED与急性活动性TED平均差-1.78(95%CI -3.44至-0.13,P=0.03)。
核心结论
- 本病例对照研究提供潜在分子证据,将HPV与TED联系起来,突出HPV衣壳蛋白与TED关键自身免疫靶点之间的分子模拟。
- 这提示一种参与TED发病机制的免疫学联系,为理解和管理该病开辟新的潜在途径。
研究设计与样本
- 在佛罗里达州迈阿密Bascom Palmer眼科研究所开展的实验性研究,采用病例对照设计。
- 使用美国国家生物技术信息中心基本局部比对搜索工具,搜索TSHR与IGF-1R蛋白同多种病毒蛋白组的氨基酸序列同源性,病毒包括乳头瘤病毒科、副黏病毒科、疱疹病毒科、肠道病毒、多瘤病毒科和弹状病毒科。
- 对11例接受眶减压手术的TED患者和11例接受眼睑成形术的对照者的眶脂肪组织样本行酶联免疫测定,以量化抗病毒抗体滴度。
- 参与者于2021年12月至2023年8月入组,样本于2023年9月检测和分析。
- 回顾人口学特征和临床数据。
主要发现
- 22例患者平均(范围)年龄58.6岁(37.4-74.4),19例(86.4%)为女性。
- 同源性分析显示TSHR与IGF-1R同HPV18 L1衣壳蛋白之间存在保守基序。
- FGXV与IXEXT+NP同源区域见于所有HPV血清型以及IGF-1R与TSHR。
- 酶联免疫测定显示对照组与慢性TED组组织HPV18 L1 IgG标准化光密度平均差-1.37(95%CI -2.64至-0.09,P=0.03),对照组均值为0.94。
- 对照组与急性活动性TED组平均差-3.15(95%CI -4.69至-1.61,P<0.001),慢性TED组与急性活动性TED组平均差-1.78(95%CI -3.44至-0.13,P=0.03),慢性TED组均值为2.31。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Thyroid eye disease (TED) is an autoimmune disease characterized by orbital inflammation and tissue remodeling. TED pathogenesis is poorly understood but is linked to autoantibodies to thyroid-stimulating hormone receptor (TSHR) and insulinlike growth factor-1 receptor (IGF-1R). OBJECTIVE: To explore the potential involvement of viral infections in TED pathogenesis. DESIGN, SETTING, AND PARTICIPANTS: In this experimental study conducted at the Bascom Palmer Eye Institute in Miami, Florida, the National Center for Biotechnology Information Basic Local Alignment Search Tool was used to search for amino acid sequence homologies between TSHR and IGF-1R proteins to various viral proteomes, including Papillomaviridae, Paramyxoviridae, Herpesviridae, Enterovirus, Polyomaviridae, and Rhabdoviridae. Participants were enrolled from December 2021 to August 2023, with the samples tested and analyzed in September 2023. Enzyme-linked immunoassays (ELISAs) were performed on orbital adipose tissue samples from 11 participants with TED undergoing orbital decompression surgery and 11 control participants undergoing blepharoplasty to quantify antiviral antibody titers. Demographic characteristics and clinical data were reviewed. MAIN OUTCOMES AND MEASURES: The main outcomes were homology analysis between TSHR and IGF-1R with several viral proteins, human papillomavirus 18 (HPV18) L1 immunoglobulin G (IgG) titers in TED orbital fat samples, and clinical characteristics associated with HPV18 L1 IgG titers. RESULTS: Among 22 total patients, mean (range) age was 58.6 years (37.4-74.4), and 19 patients (86.4%) were female. Homology analysis revealed conserved motifs between TSHR and IGF-1R with the HPV18 L1 capsid protein. Homologous regions of FGXV and IXEXT+NP were identified across all HPV serotypes and both IGF-1R and TSHR. ELISAs showed differences in the mean HPV18 L1 IgG normalized optical density levels among tissues of controls vs participants with chronic TED (mean [M], 0.94; mean differential, -1.37; 95% CI, -2.64 to -0.09; P = .03), controls vs participants with acute active TED (M, 0.94; mean differential, -3.15; 95% CI, -4.69 to -1.61; P < .001), and participants with chronic TED vs acute active TED (M, 2.31; mean differential, -1.78; 95% CI, -3.44 to -0.13; P = .03). CONCLUSIONS AND RELEVANCE: This case-control study presents potential molecular evidence linking HPV and TED, highlighting molecular mimicry between HPV capsid protein and key autoimmunity targets in TED. This suggests an immunological link contributing to TED's pathogenesis, opening new potential avenues for understanding and management of the disease.
引用
- Garg I, Meyer BI, Gallo RA, et al. Human Papillomavirus and Thyroid Eye Disease. JAMA Ophthalmol. 2025. PMID: 40272832. doi:10.1001/jamaophthalmol.2025.0847
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。